|
|
| MRD / Regn No. |
: 20220000516 |
Date |
: 23/06/2026 |
| Patient Name |
: Pallab Singh |
Age & Gender |
: 51 Yrs. / Male |
| Contact No. |
: 8250423080 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (18/May/2022) | A2G1 DKD (18/May/2022) | DYSLIPIDEMIA (18/May/2022) | |
|
Subjective |
: |
T2DM FOR 7 YEARS,LOST TO FOLLOW UP
|
|
Objective |
: |
NONE |
|
Analysis |
: |
T2DM UNCONTROLLED,LOWER EF WITH MILD INCREASE IN E/E PRIME,A3G1 DKD |
|
Plan |
: |
START GLP1RA SGLT2I,ADD ARB,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
CREATININE: 1.2 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 67.91 mL/min/1.73m2 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
2 |
INJECTION SEMAGLUTIDE
SEMATRINITY 0.25
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA VOMITING OR VISUAL DISTURBANCES | |
|
3 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
4 |
TELMISARTAN 40 MG
TELMA 40 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 23/Jun/2026 |
| Tests Suggested For Next Visit |
: FBS 2H PP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |